EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol Inhibits IgE‐Mediated Mast Cell Degranulation and Anaphylaxis in Mice

Xiaohui Yang, Dohyeon Lee, Hyun-Woo Kim, Byung-Hyun Park iD, Changjin Lim, Eun Ju Bae iD

Molecular Nutrition & Food Research · 2024

DOI: 10.1002/mnfr.202300136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2024. Verfasst von Xiaohui Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jeonbuk National University, Jeonju, 54896, Republic of Korea. Hauptthemen laut MEDLINE: Anaphylaxis, Cannabidiol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Technology Innovation Program funded by the Ministry of Trade, Industry & Energy of Korea, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scope Cannabidiol (CBD), the most abundant non‐psychoactive constituent of the plant Cannabis sativa , is known to possess immune modulatory properties. This study investigates the effects of CBD on mast cell degranulation in human and mouse primary mast cells and passive cutaneous anaphylaxis in mice. Methods and results Mouse bone marrow‐derived mast cells and human cord‐blood derived mast cells are generated. CBD suppressed antigen‐stimulated mast cell degranulation in a concentration‐dependent manner. Mechanistically, CBD inhibited both the phosphorylation of FcεRI downstream signaling molecules and calcium mobilization in mast cells, while exerting no effect on FcεRI expression and IgE binding to FcεRI. These suppressive effects are preserved in the mast cells that are depleted of type 1 (CB1) and type 2 (CB2) cannabinoid receptors, as well as in the presence of CB1 agonist, CB2 agonist, CB1 inverse agonist, and CB2 inverse agonist. CBD also inhibited the development of mast cells in a long‐term culture. The intraperitoneal administration of CBD suppressed passive cutaneous anaphylaxis in mice as evidenced by a reduction in ear swelling and decrease in the number of degranulated mast cells. Conclusion Based on these results, the administration of CBD is a new therapeutic intervention in mast cell‐associated anaphylactic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnaphylaxisCannabidiolMiceHumansAnimalsMast CellsCell DegranulationDrug Inverse AgonismImmunoglobulin EReceptors, IgE

Stichwörter der Autor:innen

Cannabidiolanaphylaxisdegranulationdifferentiationmast cells

Substanzen

CannabidiolImmunoglobulin EReceptors, IgE

Autor:innen und Institutionen

  • School of Pharmacy, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
  • Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, 54596, Republic of Korea.
  • Department of Biochemistry and Molecular Biology, Jeonbuk National University Medical School, Jeonju, 54896, Republic of Korea.

ORCID-Profile: Byung-Hyun Park, Eun Ju Bae

Förderung

  • Technology Innovation Program funded by the Ministry of Trade, Industry & Energy of Korea
  • National Research Foundation of Korea

Zitieren

APA

Yang, X., Lee, D., Kim, H. W., Park, B. H., Lim, C., & Bae, E. J. (2024). Cannabidiol Inhibits IgE‐Mediated Mast Cell Degranulation and Anaphylaxis in Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300136

Vancouver

Yang X, Lee D, Kim HW, Park BH, Lim C, Bae EJ. Cannabidiol Inhibits IgE‐Mediated Mast Cell Degranulation and Anaphylaxis in Mice. Molecular Nutrition & Food Research. 2024. doi:10.1002/mnfr.202300136

BibTeX
@article{Yang2024,
  author = {Yang, Xiaohui and Lee, Dohyeon and Kim, Hyun-Woo and Park, Byung-Hyun and Lim, Changjin and Bae, Eun Ju},
  title = {Cannabidiol Inhibits IgE‐Mediated Mast Cell Degranulation and Anaphylaxis in Mice},
  journal = {Molecular Nutrition & Food Research},
  year = {2024},
  doi = {10.1002/mnfr.202300136}
}
Kostenlos starten →